Treace Medical Concepts, Inc. (TMCI) vs Vanda Pharmaceuticals Inc. (VNDA)

A side-by-side comparison of Treace Medical Concepts, Inc. and Vanda Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — TMCI vs VNDA

growth of $100 · dividends reinvested · last 5y
TMCI -82.5% (-29.4%/yr)VNDA -72.3% (-22.7%/yr)VNDA compounded faster over this window
050100150Start $10020222023202420252026$18$28
TMCI VNDA

TMCI vs VNDA: by the numbers

  • •VNDA is the larger company ($270M vs $266M market cap).
  • •Both run net losses; TMCI's is the smaller (-28.99% vs -127.41% net margin).
  • •TMCI grew revenue faster over the past five years (21.44% vs -3.56% CAGR).

Metrics side by side

Valuation

MetricTMCIVNDA
P/S ratio1.301.25
P/B ratio3.931.23

Profitability

MetricTMCIVNDA
Gross margin79.45%92.82%
Operating margin-26.17%-69.95%
Net margin-28.99%-127.41%
ROE-87.86%-124.83%
ROIC-37.64%-74.73%

Growth (annualized)

MetricTMCIVNDA
Revenue CAGR (5Y)21.44%-3.56%
Total return CAGR (5Y)-29.41%-23.91%

Frequently asked

Which has grown faster, TMCI or VNDA?
Over the past five years, TMCI grew revenue faster — TMCI at a 21.44% CAGR versus VNDA at -3.56%.
How have TMCI and VNDA total returns compared?
Over the past 5 years, TMCI delivered -29.41% and VNDA delivered -23.91% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.